Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set

RMD Open

Volumn 2, Issue 1, 2016, Pages

  Kalyoncu, Umut ^a,b   Ogdie, Alexis ^c   Campbell, Willemina ^d   Bingham, Clifton O ^a   De Wit, Maarten ^e   Gladman, Dafna D ^f   Mease, Philip ^g   Steinkoenig, Ingrid ^h   Strand, Vibeke ⁱ   Riese, Victoria G ^a,j   Orbai, Ana Maria ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Patient Partner   (Canada)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF WASHINGTON   (United States)

^h Patient Research Partner   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j NATIONAL INSTITUTES OF HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988409763     PISSN: None     EISSN: 20565933     Source Type: Journal    
DOI: 10.1136/rmdopen-2015-000217     Document Type: Article

References (24)

1. Kane D, Stafford L, Bresnihan B, et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003;42:1460-8.
2. Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010;34: J314-21.
3. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
4. Ogdie A, Langan S, Love T, et al. Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) 2013;52:568-75.
5. Zachariae H, Zachariae R, Blomqvist K, et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol 2002;82:108-13.
6. Taylor WJ, Mease PJ, Adebajo A, et al. Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health. J Rheumatol 2010;37:1885-91.
7. Rosen CF, Mussani F, Chandran V, et al. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology (Oxford) 2012;51:571-6.
8. Gladman DD, Mease PJ, Strand V, et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007;34:1167-70.
9. Tillett W, Adebajo A, Brooke M, et al. Patient involvement in outcome measures for psoriatic arthritis. Curr Rheumatol Rep 2014;16:418.
10. Tillett W, Eder L, Goel N, et al. Enhanced patient involvement and the need to revise the core set - report from the psoriatic arthritis working group at OMERACT 2014. J Rheumatol 2015;42:2198-203.
11. Gossec L, de Wit M, Kiltz U, et al. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 2014;73:1012-19.
12. Palominos PE, Gaujoux-Viala C, Fautrel B, et al. Clinical outcomes in psoriatic arthritis: a systematic literature review. Arthritis Care Res (Hoboken) 2012;64:397-406.
13. de Wit M, Campbell W, FitzGerald O, et al. Patient participation in psoriasis and psoriatic arthritis outcome research: a report from the GRAPPA 2013 Annual Meeting. J Rheumatol 2014;41:1206-11.
14. Glanville JM, Lefebvre C, Miles JN, et al. How to identify randomized controlled trials in MEDLINE: ten years on. J Med Libr Assoc 2006;94:130-6.
15. Lefebvre C, Eisinga A, McDonald S, et al. Enhancing access to reports of randomized trials published world-wide - the contribution of EMBASE records to the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library. Emerg Themes Epidemiol 2008;5:13.
16. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006-12.
17. Kirwan JR, Boers M, Tugwell P. Updating the OMERACT filter at OMERACT 11. J Rheumatol 2014;41:975-7.
18. Boers M, Kirwan J, Tugwell P, et al. The OMERACT Handbook. OMERACT, 2014.
19. Gladman DD, Chandran V. Review of clinical registries of psoriatic arthritis: lessons learned?: value for the future? Curr Rheumatol Rep 2011;13:346-52.
20. Moverley AR, Vinall-Collier KA, Helliwell PS. It's not just the joints, it's the whole thing: qualitative analysis of patients' experience of flare in psoriatic arthritis. Rheumatology (Oxford) 2015;54: 1448-53.
21. Stamm TA, Nell V, Mathis M, et al. Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Rheum 2007;57: 487-94.
22. Coylewright M, Palmer R, O'Neill ES, et al. Patient-defined goals for the treatment of severe aortic stenosis: a qualitative analysis. Health Expect 2015. doi:10.1111/hex.12393. [Epub ahead of print 14 Aug 2015].
23. Singer JP, Chen J, Katz PP, et al. Defining novel health-related quality of life domains in lung transplantation: a qualitative analysis. Qual Life Res 2015;24:1521-33.
24. van Tuyl LH, Hewlett S, Sadlonova M, et al. The patient perspective on remission in rheumatoid arthritis: 'You've got limits, but you're back to being you again'. Ann Rheum Dis 2015;74: 1004-10.